8-K: Celcuity Inc. Stockholder Meeting Approves New Incentive Plan

Celcuity Inc. announced the approval of its 2026 Stock Incentive Plan and Amended and Restated 2017 Employee Stock Purchase Plan by stockholders at the 2026 Annual Meeting.

Summary

• Celcuity Inc. held its 2026 Annual Meeting of Stockholders on May 14, 2026.
• Stockholders approved the 2026 Stock Incentive Plan, which replaces the prior plan, allowing for the issuance of up to 3,000,000 shares of common stock.
• The 2026 Plan permits awards to employees, consultants, and non-employee directors in various forms, including stock options and restricted stock.
• The Amended and Restated 2017 Employee Stock Purchase Plan (ESPP) was also approved, increasing the available shares by 289,199 and extending its expiration by ten years.
• Eight directors were elected to the Board of Directors.
• Boulay PLLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
• Advisory approval was given for the compensation of named executive officers.
• The 2026 Plan and Restated ESPP became effective upon stockholder approval.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it reflects routine corporate governance actions and stockholder approvals necessary for ongoing operations and employee incentives, without significant new financial performance data.

Positives

• Stockholder approval of the 2026 Stock Incentive Plan provides a framework for future equity-based compensation to attract and retain talent.
• The Amended and Restated ESPP enhances the employee stock purchase program with additional shares and an extended term, potentially increasing employee participation and ownership.
• Election of all eight director nominees indicates strong support for the current board.
• Ratification of Boulay PLLP as auditor suggests confidence in their oversight.
• Strong 'For' votes on the Restated ESPP (35,067,849) and the 2026 Plan (28,691,350) show significant stockholder support for these initiatives.

Negatives

• A notable number of 'Against' votes for the 2026 Plan (9,002,785) indicates some stockholder dissent regarding the equity incentive structure.
• The presence of 3,622,556 Broker Non-Votes across several proposals suggests a portion of shares were not voted by brokers, potentially due to lack of instruction.

Risks

• Dilution risk for existing shareholders due to the potential issuance of up to 3,000,000 shares under the 2026 Stock Incentive Plan.
• Potential for future disagreements or concerns from stockholders regarding executive compensation, as indicated by advisory vote results.

Future Outlook

The approval of the 2026 Stock Incentive Plan and the Restated ESPP provides the company with tools to incentivize employees and potentially raise capital through stock issuances in the future, subject to market conditions and plan administration.

Management Comments

• The 2026 Stock Incentive Plan was approved by the Board of Directors subject to Stockholder approval.
• The Amended and Restated 2017 Employee Stock Purchase Plan was approved by the Board of Directors subject to Stockholder approval.
• The 2026 Plan became effective at the time of Stockholder approval.
• The Restated ESPP became effective at the time of Stockholder approval.

Industry Context

StockSavvy.ai notes that the approval of new stock incentive plans and employee stock purchase plans is a common practice for publicly traded companies, particularly in the biotechnology and technology sectors, to align employee interests with shareholder value and attract competitive talent.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for dilution from new equity awards under the 2026 Plan, but also alignment of interests through equity incentives. Increased share availability under ESPP may encourage employee investment.
• Employees: Enhanced opportunities for equity compensation and stock purchase through the new 2026 Plan and Restated ESPP.
• Directors: Continued service on the Board, with potential for equity awards under the 2026 Plan.
• Management: Will administer the new equity plans and may receive awards under them.

Next Steps

• Awards may be granted under the 2026 Stock Incentive Plan to employees, consultants, and non-employee directors.
• The company will continue to operate under the terms of the Restated ESPP.
• The Board of Directors will oversee the administration of the 2026 Plan by its Compensation Committee.

Key Dates

Keywords

Celcuity Inc., 8-K Filing, Stock Incentive Plan, Employee Stock Purchase Plan, Annual Meeting, Board of Directors, Equity Compensation, Stockholder Approval